Recommendations for the use of ECT in pregnancy: literature review and proposed clinical protocol
Tóm tắt
Psychiatric disorders are common in pregnancy, affecting 15–29% of pregnant women. Untreated depression has negative health consequences for mother and fetus. Electroconvulsive therapy (ECT) is an effective option for the treatment of severe depression, high suicide risk, catatonia, medication-resistant illness, psychotic agitation, severe physical decline, and other life-threatening conditions. To our knowledge, however, there is no literature that consolidates all the evidence on maternal and fetal risks associated with untreated depression, medications, and ECT then translating it into one cohesive protocol that could serve as a management guide and a source of reassurance to health-care providers involved in such practice. Hoping to facilitate ECT access to perinatal patients, the authors combined their multidisciplinary clinical experience (in perinatal psychiatry, neuropsychiatry and neuromodulation, and anesthesiology) at three different centers in the USA (Brigham and Women’s Hospital/Harvard Medical School, The University of Chicago, and Brown University) with a careful and critical literature review and propose guidelines for the administration of ECT in pregnancy. A comprehensive review of the relevant literature regarding both ECT and psychotropic medications in pregnancy was performed, including meta-analyses of randomized controlled trials published in general medicine, anesthesiology, psychiatry, and obstetrics journals and guidelines. The indication and appropriateness of ECT in pregnancy must be carefully weighed against the risks of untreated maternal illness and those of alternative treatment options. The safety of ECT in pregnancy has been documented over the last 50 years. The adverse effects in pregnancy are similar to the risks of ECT in any individual. The most common risk to the mother is premature contractions and preterm labor, which occur infrequently and are not clearly caused by ECT. The rates of miscarriages were not significantly different from that of the general population. There have been no associations of ECT with congenital anomalies, either morphologic or behavioral, and no neurocognitive disturbances in the child. ECT is a reasonably safe and effective treatment alternative for management of many psychiatric disorders in pregnant patients. The authors provide recommendations for treatment modifications in pregnancy-based physiologic changes that occur during that period and consolidate them into a protocol that can assist clinicians in improving access and safety of ECT for pregnant patients.
Tài liệu tham khảo
Abou-Arab MH, Rostrup M, Heier T (2016) Dose requirements of alfentanil to eliminate autonomic responses during rapid-sequence induction with thiopental 4 mg/kg and rocuronium 0.6 mg/kg. J Clin Anesth 35:465–474
Abrams R (2002) Electroconvulsive therapy, 4th edn. Oxford University Press, New York
Anderson EL, Reti IM (2009) ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom Med 71(2):235–242
APA (2001) American Psychiatric Association: the practice of electroconvulsive therapy: recommendations for treatment, training, and privileging (a Task Force Report of the American Psychiatric Association), 2nd edn. American Psychiatric Publishing, Washington, D.C.
Balki M, Castro C, Ananthanarayan C (2006) Status epilepticus after electroconvulsive therapy in a pregnant patient. Int J Obstet Anesth 15(4):325–328
Braden A, Maani C, Nagy C (2016) Anesthetic management of an ex utero intrapartum treatment procedure: a novel balanced approach. J Clin Anesth 31:60–63
Broussard CN, Richter JE (1998) Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options? Drug Saf 19(4):325–337
Bulbul F, Copoglu US, Alpak G, Unal A, Demir B, Tastan MF, Savas HA (2013) Electroconvulsive therapy in pregnant patients. Gen Hosp Psychiatry 35(6):636–639
Burke L (2003) The impact of maternal depression on familial relationships. Int Rev Psychiatry 15(3):243–255
Chang SS, Renshaw DC (1986) Psychosis and pregnancy. Compr Ther 12(10):36–41
Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, Suri R, Burt VK, Hendrick V, Reminick AM, Loughead A, Vitonis AF, Stowe ZN (2006) Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295(5):499–507
Committee ADRA (1998) Premature closure of the fetal ductus arteriosus after maternal use of non-steroidal anti-inflammatory drugs. Med J Aust 169(5):270–271
Deguchi S, Komasawa N, Ueno T, Omori M, Minami T (2016) Evaluation of pH on removed tracheal tubes after general anesthesia: a prospective observational study. J Clin Anesth 35:346–349
Doktorchik C, Premji S, Slater D, Williamson T, Tough S, Patten S (2017) Patterns of change in anxiety and depression during pregnancy predict preterm birth. J Affect Disord 227:71–78
Echevarria Moreno M, Martin Munoz J, Sanchez Valderrabanos J, Vazquez Gutierrez T (1998) Electroconvulsive therapy in the first trimester of pregnancy. J ECT 14(4):251–254
Flynn HA, Davis M, Marcus SM, Cunningham R, Blow FC (2004) Rates of maternal depression in pediatric emergency department and relationship to child service utilization. Gen Hosp Psychiatry 26(4):316–322
Folk JW, Kellner CH, Beale MD, Conroy JM, Duc TA (2000) Anesthesia for electroconvulsive therapy: a review. J ECT 16(2):157–170
Forssman H (1955) Follow-up study of sixteen children whose mothers were given electric convulsive therapy during gestation. Acta Psychiatr Neurol Scand 30(3):437–441
Gaynes BN, Gavin N, Meltzer-Brody S et al (2005) Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ) (119):1–8
Hattori K, Komasawa N, Miyazaki Y, Kido H, Deguchi S, Minami T (2016) Muscle relaxant facilitates i-gel insertion by novice doctors: a prospective randomized controlled trial. J Clin Anesth 33:218–222
Heath C, Yonkers KA (2001) Somatic treatments in depression: concerns during pregnancy and breastfeeding. In: Yonkers KALB (ed) Management of psychiatric disorders in pregnancy. Arnold, London, pp 82–104
Herman NL, Li AT, Van Decar TK et al (2000) Transfer of methohexital across the perfused human placenta. J Clin Anesth 12(1):25–30
Holdcroft A, Robinson MJ, Gordon H, Whitwam JG (1974) Comparison of effect of two induction doses of methohexitone on infants delivered by elective caesarean section. Br Med J 2(5917):472–475
Holland J, Brown R (2017) Neonatal venlafaxine discontinuation syndrome: a mini-review. Eur J Paediatr Neurol 21(2):264–268
Huybrechts KF, Bateman BT, Desai RJ et al (2017) Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study. BMJ 358:j3326
Impastato DJ, Gabriel AR, Lardaro HH (1964) Electric and insulin shock therapy during pregnancy. Dis Nerv Syst 25:542–546
Ishikawa T, Kawahara S, Saito T, Otsuka H, Kemmotsu O, Hirayama E, Ebina Y, Fujimoto S, Inoue T, Koyama T (2001) Anesthesia for electroconvulsive therapy during pregnancy—a case report. Masui 50(9):991–997
Jauniaux E, Gulbis B, Shannon C, Maes V, Bromley L, Rodeck C (1998) Placental propofol transfer and fetal sedation during maternal general anaesthesia in early pregnancy. Lancet 352(9124):290–291
Kasar M, Saatcioglu O, Kutlar T (2007) Electroconvulsive therapy use in pregnancy. J ECT 23(3):183–184
Kessler RC (2003) Epidemiology of women and depression. J Affect Disord 74(1):5–13
Koren G, Pastuszak A, Ito S (1998) Drugs in pregnancy. N Engl J Med 338(16):1128–1137
Kramer BA (1990) Electroconvulsive therapy use during pregnancy. West J Med 152(1):77
Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O (2000) Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol 95(4):487–490
Leboulanger N, Louvet N, Rigouzzo A, de Mesmay M, Louis B, Farrugia M, Girault L, Ramirez A, Constant I, Jouannic JM, Fauroux B (2014) Pregnancy is associated with a decrease in pharyngeal but not tracheal or laryngeal cross-sectional area: a pilot study using the acoustic reflection method. Int J Obstet Anesth 23:35–39
Lee SH, Lee SE, Chung S, Lee HJ, Jeong S (2016) Impact of time interval between remifentanil and propofol on propofol injection pain. J Clin Anesth 34:510–515
Leiknes KA, Cooke MJ, Jarosch-von Schweder L, Harboe I, Hoie B (2015) Electroconvulsive therapy during pregnancy: a systematic review of case studies. Arch Womens Ment Health 18(1):1–39
Levy G (1981) Pharmacokinetics of fetal and neonatal exposure to drugs. Obstet Gynecol 58(5 Suppl):9S–16S
Loubert C, Gagnon PO, Fernando R (2017) Minimum effective fluid volume of colloid to prevent hypotension during caesarean section under spinal anesthesia using a prophylactic phenylephrine infusion: an up-down sequential allocation study. J Clin Anesth 36:194–200
Lovas A, Almos PZ, Peto Z, Must A, Horvath S (2011) Anesthesia for electroconvulsive therapy in early pregnancy. J ECT 27(4):328–330
Lu Z, Rosenberg H, Li G (2017) Prevalence of malignant hyperthermia diagnosis in hospital discharge records in California, Florida, New York, and Wisconsin. J Clin Anesth 39:10–14
Marmorstein NR, Malone SM, Iacono WG (2004) Psychiatric disorders among offspring of depressed mothers: associations with paternal psychopathology. Am J Psychiatry 161(9):1588–1594
Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW, NEAD Study Group (2009) Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 360(16):1597–1605
Miller LJ (1994) Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry 45(5):444–450
Mirkin BL (1976) Drug disposition and therapy in the developing human being. Pediatr Ann 5(9):542–557
Mon W, Stewart A, Fernando R, Ashpole K, el-Wahab N, MacDonald S, Tamilselvan P, Columb M, Liu YM (2017) Cardiac output changes with phenylephrine and ephedrine infusions during spinal anesthesia for cesarean section: a randomized, double-blind trial. J Clin Anesth 37:43–48
Moya F, Kvisselgaard N (1961) The placental transmission of succinylcholine. Anesthesiology 22:1–6
Murray L, Stein A (1989) The effects of postnatal depression on the infant. Baillieres Clin Obstet Gynaecol 3(4):921–933
Nishikawa K, Yamakage M (2017) Effects of the concurrent use of a reduced dose of propofol with divided supplemental remifentanil and moderate hyperventilation on duration and morphology of electroconvulsive therapy-induced electroencephalographic seizure activity: a randomized controlled trial. J Clin Anesth 37:63–68
Nonacs R, Cohen LS (2003) Assessment and treatment of depression during pregnancy: an update. Psychiatr Clin North Am 26(3):547–562
O'Reardon JP, Cristancho MA, von Andreae CV, Cristancho P, Weiss D (2011) Acute and maintenance electroconvulsive therapy for treatment of severe major depression during the second and third trimesters of pregnancy with infant follow-up to 18 months: case report and review of the literature. J ECT 27(1):e23–e26
Pacifici GM, Nottoli R (1995) Placental transfer of drugs administered to the mother. Clin Pharmacokinet 28(3):235–269
Pearson RM, Campbell A, Howard LM et al (2017) Impact of dysfunctional maternal personality traits on risk of offspring depression, anxiety and self-harm at age 18 years: a population-based longitudinal study. Psychol Med 1–11
Polster DS, Wisner KL (1999) ECT-induced premature labor: a case report. J Clin Psychiatry 60(1):53–54
Pompili M, Dominici G, Giordano G, Longo L, Serafini G, Lester D, Amore M, Girardi P (2014) Electroconvulsive treatment during pregnancy: a systematic review. Expert Rev Neurother 14(12):1377–1390
Pourafkari N, Pourafkari L, Nader ND (2016) Electroconvulsive therapy for depression following acute coronary syndromes: a concern for the anesthesiologist. J Clin Anesth 31:223–228
Psychiatrists RCo (2005) The ECT handbook: the third report of the Royal College of Psychiatrist’s Special Committee on ECT. Royal College of Psychiatrists, London
Ray-Griffith SL, Coker JL, Rabie N, Eads LA, Golden KJ, Stowe ZN (2016) Pregnancy and electroconvulsive therapy: a multidisciplinary approach. J ECT 32(2):104–112
Reis M, Kallen B (2008) Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 28(3):279–288
Rowe TF (1997) Acute gastric aspiration: prevention and treatment. Semin Perinatol 21(4):313–319
Salzbrenner S, Breeden A, Jarvis S, Rodriguez W (2011) A 48-year-old woman primigravid via in vitro fertilization with severe bipolar depression and preeclampsia treated successfully with electroconvulsive therapy. J ECT 27(1):e1–e3
Sanchez-Alcaraz A, Quintana MB, Laguarda M (1998) Placental transfer and neonatal effects of propofol in caesarean section. J Clin Pharm Ther 23(1):19–23
Sherer DM, D'Amico ML, Warshal DP, Stern RA, Grunert HF, Abramowicz JS (1991) Recurrent mild abruptio placentae occurring immediately after repeated electroconvulsive therapy in pregnancy. Am J Obstet Gynecol 165(3):652–653
Sinha P, Goyal P, Andrade C (2017) A meta-review of the safety of electroconvulsive therapy in pregnancy. J ECT 33(2):81–88
Straub H, Adams M, Kim JJ, Silver RK (2012) Antenatal depressive symptoms increase the likelihood of preterm birth. Am J Obstet Gynecol 207(4):329 e321–329 e324
Teh SP, Helmes E, Drake DG (2007) A Western Australian survey on public attitudes toward and knowledge of electroconvulsive therapy. Int J Soc Psychiatry 53(3):247–273
The practice of electroconvulsive therapy (2002) Recommendations for treatment, training, and privileging: a Task Force Report of the American Psychiatric Association, 2nd ed. Am J Psychiatry 159(2):331
Vesga-Lopez O, Blanco C, Keyes K, Olfson M, Grant BF, Hasin DS (2008) Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 65(7):805–815
Viguera AC, Whitfield T, Baldessarini RJ et al (2007) Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 164(12):1817–1824 quiz 1923
Vitale SG, Lagana AS, Muscatello MR et al (2016) Psychopharmacotherapy in pregnancy and breastfeeding. Obstet Gynecol Surv 71(12):721–733
Walker R, Swartz CM (1994) Electroconvulsive therapy during high-risk pregnancy. Gen Hosp Psychiatry 16(5):348–353
Wise MG, Ward SC, Townsend-Parchman W, Gilstrap LC 3rd, Hauth JC (1984) Case report of ECT during high-risk pregnancy. Am J Psychiatry 141(1):99–101
Wisner KL, Perel JM (1998) Psychopharmacologic agents and electroconvulsive therapy dur-ing pregnancy and the puerperium. In: Psychiatric consultation in childbirth settings: parent- and child-oriented approaches. New York: Plenum